112 related articles for article (PubMed ID: 35730359)
1. Associations between HIV viremia during antiretroviral therapy and cardiovascular disease.
Elvstam O; Marrone G; Engström G; Nilsson PM; Carlander C; Treutiger CJ; Gisslén M; Björkman P
AIDS; 2022 Nov; 36(13):1829-1834. PubMed ID: 35730359
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study.
Brattgård H; Björkman P; Nowak P; Treutiger CJ; Gisslén M; Elvstam O
PLoS One; 2022; 17(5):e0268540. PubMed ID: 35580115
[TBL] [Abstract][Full Text] [Related]
3. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
Mugavero MJ; Napravnik S; Cole SR; Eron JJ; Lau B; Crane HM; Kitahata MM; Willig JH; Moore RD; Deeks SG; Saag MS;
Clin Infect Dis; 2011 Nov; 53(9):927-35. PubMed ID: 21890751
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid Levels and Incidence of Invasive Cancer in People With HIV After Initiation of Combination Antiretroviral Therapy.
Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Svedhem V; Gisslén M; Björkman P
Open Forum Infect Dis; 2021 Jun; 8(6):ofab131. PubMed ID: 34189159
[TBL] [Abstract][Full Text] [Related]
5. Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort.
Elvstam O; Malmborn K; Elén S; Marrone G; García F; Zazzi M; Sönnerborg A; Böhm M; Seguin-Devaux C; Björkman P
Clin Infect Dis; 2023 Jan; 76(1):25-31. PubMed ID: 36100984
[TBL] [Abstract][Full Text] [Related]
6. All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study.
Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Sönnerborg A; Gisslén M; Björkman P
Clin Infect Dis; 2021 Jun; 72(12):2079-2086. PubMed ID: 32271361
[TBL] [Abstract][Full Text] [Related]
7. Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy.
Zhang S; van Sighem A; Kesselring A; Gras L; Smit C; Prins JM; Kauffmann R; Richter C; de Wolf F; Reiss P
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):265-72. PubMed ID: 22531756
[TBL] [Abstract][Full Text] [Related]
8. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Namane T; Mpholo T; Battegay M; Klimkait T; Labhardt ND
PLoS Med; 2020 Sep; 17(9):e1003325. PubMed ID: 32936795
[TBL] [Abstract][Full Text] [Related]
9. Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.
Elvstam O; Medstrand P; Yilmaz A; Isberg PE; Gisslén M; Björkman P
PLoS One; 2017; 12(7):e0180761. PubMed ID: 28683128
[TBL] [Abstract][Full Text] [Related]
10. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure.
Joya C; Won SH; Schofield C; Lalani T; Maves RC; Kronmann K; Deiss R; Okulicz J; Agan BK; Ganesan A
Clin Infect Dis; 2019 Nov; 69(12):2145-2152. PubMed ID: 30785191
[TBL] [Abstract][Full Text] [Related]
11. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
[TBL] [Abstract][Full Text] [Related]
12. Association of low-level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study.
Yu H; Yang Y; Cao D; Zhao Y; Jin C; Sun H; Cao Y; Ye R; Yao S; Duan S; Wu Z
HIV Med; 2023 Jan; 24(1):37-45. PubMed ID: 35578387
[TBL] [Abstract][Full Text] [Related]
13. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
[TBL] [Abstract][Full Text] [Related]
14. Persistent Low-level Viremia Predicts Subsequent Virologic Failure: Is It Time to Change the Third 90?
Esber A; Polyak C; Kiweewa F; Maswai J; Owuoth J; Maganga L; Adamu Y; Hickey PW; Ake JA; Crowell TA
Clin Infect Dis; 2019 Aug; 69(5):805-812. PubMed ID: 30462188
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of persistent low-level viremia among HIV patients on antiretroviral therapy: A prospective cohort study.
Ding H; Xu J; Liu J; Wang Q; Kang J; Li X; Zhang Z; Han X; Jiang Y; Geng W; Shang H
HIV Med; 2022 Mar; 23 Suppl 1():64-71. PubMed ID: 35293103
[TBL] [Abstract][Full Text] [Related]
16. Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.
Liu P; You Y; Liao L; Feng Y; Shao Y; Xing H; Lan G; Li J; Ruan Y; Li D
BMC Infect Dis; 2022 May; 22(1):426. PubMed ID: 35509014
[TBL] [Abstract][Full Text] [Related]
17. Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999-2018).
Schmidt D; Kollan C; Stoll M; Hamouda O; Bremer V; Kurth T; Bartmeyer B; ;
BMC Public Health; 2021 Jan; 21(1):200. PubMed ID: 33482773
[TBL] [Abstract][Full Text] [Related]
18. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
[TBL] [Abstract][Full Text] [Related]
19. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.
Mugavero MJ; Amico KR; Westfall AO; Crane HM; Zinski A; Willig JH; Dombrowski JC; Norton WE; Raper JL; Kitahata MM; Saag MS
J Acquir Immune Defic Syndr; 2012 Jan; 59(1):86-93. PubMed ID: 21937921
[TBL] [Abstract][Full Text] [Related]
20. Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
Teira R; Vidal F; Muñoz-Sánchez P; Geijo P; Viciana P; Ribera E; Domingo P; Castaño M; Martínez E; Roca B; Puig T; Estrada V; Deig E; Galindo MJ; de la Fuente B; Lozano F; Montero M; Muñoz-Sanz A; Sanchez T; Terrón A; Romero-Palacios A; Lacalle JR; Garrido M; Suárez-Lozano I;
HIV Med; 2017 Mar; 18(3):196-203. PubMed ID: 27476742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
